 |
|
Racial Differences in Screening for Prostate Cancer in the Elderly
Timothy Gilligan, MD;
Philip S. Wang, MD, DrPH;
Raisa Levin, MS;
Philip W. Kantoff, MD;
Jerry Avorn, MD
Arch Intern Med. 2004;164:1858-1864.
Background Black men are more likely than white men to be diagnosed as having advanced prostate cancer, and their prostate cancer mortality rates are more than twice as high. Low screening rates among black men may contribute to these disparities, but there are few data on racial differences in prostate cancer screening.
Objectives To present a case-control study of racial differences in the use of prostate-specific antigen (PSA) as a screening test among Medicare beneficiaries in New Jersey and to assess the degree to which race is associated with prostate cancer screening.
Methods The study used a statewide database of claims data from Medicare Parts A and B, Medicaid, and the state's Pharmaceutical Assistance for the Aged and Disabled program. Prevalent cases of prostate cancer were excluded using the state's cancer registry. Of 139 672 men who underwent PSA screening, 34 984 were randomly selected along with an identical number of controls matched by month and year of birth. After men with International Classification of Diseases, Ninth Revision, Clinical Modification,or Current Procedural Terminology codes indicative of prostate cancer were excluded, 33 463 case patients and 33 782 control subjects remained.
Results The use of PSA screening was strongly and inversely associated with black race (odds ratio [OR] = 0.50; P<.001), poverty (OR = 0.33; P<.001), and near poverty (OR = 0.69; P<.001). Multivariate logistic regression analysis after age, socioeconomic status, comorbidity, and use of health care services were controlled for revealed that black race remained a strong predictor of not undergoing PSA screening (OR = 0.65; 95% confidence interval, 0.60-0.70).
Conclusions Elderly blacks are substantially less likely to undergo PSA screening than elderly whites. Differences in socioeconomic status and comorbid conditions explain only a small part of the racial differences in screening rates.
From the Department of Medical Oncology, Dana-Farber Cancer Institute (Drs Gilligan and Kantoff), and the Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital (Drs Wang and Avorn and Ms Levin), Boston, Mass. The authors have no relevant financial interest in this article.
RELATED ARTICLE
Prostate Cancer Screening: A Racial Dichotomy
Isis Calsoyas and M. Suzanne Stratton
Arch Intern Med. 2004;164(17):1830-1832.
EXTRACT
| FULL TEXT
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
|
The Internet as an Emerging Patient Education Tool Among African American Men With Prostate Cancer: An Exploratory Study
Wallington
American Journal of Men's Health 2008;2:106-121.
ABSTRACT
Prostate Cancer Screening in African American Men: Barriers and Methods for Improvement
Reynolds
American Journal of Men's Health 2008;2:172-177.
ABSTRACT
Impact of Primary Care Patient Visits on Racial and Ethnic Disparities in Preventive Care in the United States
Fiscella and Holt
J Am Board Fam Med 2007;20:587-597.
ABSTRACT
| FULL TEXT
Differences in Prognostic Factors and Survival among White Men and Black Men with Prostate Cancer, California, 1995-2004
Robbins et al.
Am J Epidemiol 2007;166:71-78.
ABSTRACT
| FULL TEXT
Fear, Knowledge, and Efficacy Beliefs Differentially Predict the Frequency of Digital Rectal Examination Versus Prostate Specific Antigen Screening in Ethnically Diverse Samples of Older Men
Consedine et al.
American Journal of Men's Health 2007;1:29-43.
ABSTRACT
PSA Screening Among Elderly Men With Limited Life Expectancies.
Walter et al.
JAMA 2006;296:2336-2342.
ABSTRACT
| FULL TEXT
Prostate Cancer Screening: A Racial Dichotomy
Calsoyas and Stratton
Arch Intern Med 2004;164:1830-1832.
FULL TEXT
|
